PT1194140E - Composicao farmaceutica contendo fenofibrato e processo de preparacao - Google Patents

Composicao farmaceutica contendo fenofibrato e processo de preparacao

Info

Publication number
PT1194140E
PT1194140E PT00949677T PT00949677T PT1194140E PT 1194140 E PT1194140 E PT 1194140E PT 00949677 T PT00949677 T PT 00949677T PT 00949677 T PT00949677 T PT 00949677T PT 1194140 E PT1194140 E PT 1194140E
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
phenofibrate
surfactant
preparation process
cellulose derivative
Prior art date
Application number
PT00949677T
Other languages
English (en)
Inventor
Pascal Suplie
Bruno Criere
Philippe Chenevier
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1194140(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of PT1194140E publication Critical patent/PT1194140E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
PT00949677T 1999-07-09 2000-07-07 Composicao farmaceutica contendo fenofibrato e processo de preparacao PT1194140E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908923A FR2795961B1 (fr) 1999-07-09 1999-07-09 Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation

Publications (1)

Publication Number Publication Date
PT1194140E true PT1194140E (pt) 2005-07-29

Family

ID=9547923

Family Applications (3)

Application Number Title Priority Date Filing Date
PT00949677T PT1194140E (pt) 1999-07-09 2000-07-07 Composicao farmaceutica contendo fenofibrato e processo de preparacao
PT05006751T PT1574214E (pt) 1999-07-09 2000-07-07 Composição farmacêutica que contém fenofibrato e processo para a sua preparação
PT04027226T PT1523983E (pt) 1999-07-09 2000-07-07 Suspensão aquosa contendo fenofibrato

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT05006751T PT1574214E (pt) 1999-07-09 2000-07-07 Composição farmacêutica que contém fenofibrato e processo para a sua preparação
PT04027226T PT1523983E (pt) 1999-07-09 2000-07-07 Suspensão aquosa contendo fenofibrato

Country Status (37)

Country Link
US (4) US7101574B1 (pt)
EP (3) EP1523983B1 (pt)
JP (2) JP4841092B2 (pt)
KR (3) KR20020025188A (pt)
CN (2) CN1204885C (pt)
AT (3) ATE399006T1 (pt)
AU (1) AU782282B2 (pt)
BG (1) BG65504B1 (pt)
BR (1) BR0012335A (pt)
CA (1) CA2377909C (pt)
CY (1) CY1106206T1 (pt)
CZ (1) CZ300094B6 (pt)
DE (3) DE60039313D1 (pt)
DK (3) DK1194140T3 (pt)
EA (1) EA004294B1 (pt)
EE (1) EE04995B1 (pt)
ES (3) ES2271924T3 (pt)
FR (1) FR2795961B1 (pt)
GE (1) GEP20043287B (pt)
HK (3) HK1044894B (pt)
HR (1) HRP20020111B1 (pt)
HU (1) HU229044B1 (pt)
IL (2) IL147499A0 (pt)
IS (1) IS2157B (pt)
ME (1) ME01361B (pt)
MX (1) MXPA02000324A (pt)
NO (1) NO333301B1 (pt)
NZ (1) NZ516416A (pt)
PL (1) PL212082B1 (pt)
PT (3) PT1194140E (pt)
RS (1) RS50035B (pt)
SI (2) SI1194140T1 (pt)
SK (1) SK287484B6 (pt)
TR (1) TR200200008T2 (pt)
UA (1) UA72925C2 (pt)
WO (1) WO2001003693A1 (pt)
ZA (1) ZA200200169B (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
FR2819720B1 (fr) * 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
AU2003270778B2 (en) 2002-09-20 2009-10-08 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
AU2003263480A1 (en) * 2002-09-24 2004-04-19 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
CN100367947C (zh) * 2002-12-04 2008-02-13 徐州恩华赛德药业有限责任公司 具有抗高血脂症的含非诺贝特的药物组合物
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
EP1829541A1 (en) * 2002-12-17 2007-09-05 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
EP1572190B1 (en) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
MXPA06000111A (es) * 2003-07-02 2006-04-27 Abbott Lab Proceso para preparar formulaciones de farmacos que regulan lipidos.
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8026281B2 (en) * 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate
BRPI0606187A2 (pt) * 2005-02-25 2009-06-09 Hoffmann La Roche comprimidos com capacidade de dispersão da substáncia do fármaco melhorada
JP2008505934A (ja) * 2005-03-30 2008-02-28 テバ ファーマシューティカル インダストリーズ リミティド メンソール又はｐｅｇ／ポロキサマーを含むフェノフィブレートの改良された製剤
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
AU2007252308A1 (en) * 2006-05-23 2007-11-29 Intelemetrix Ltd Data accessing system and method
HUE032156T2 (en) 2006-06-19 2017-09-28 Alpharma Pharmaceuticals Llc Pharmaceutical preparations
KR100767349B1 (ko) * 2006-08-01 2007-10-17 삼천당제약주식회사 페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법
EP1923053A1 (en) * 2006-09-27 2008-05-21 Novartis AG Pharmaceutical compositions comprising nilotinib or its salt
EP2073797A2 (en) * 2006-10-11 2009-07-01 Alpharma, Inc. Pharmaceutical compositions
JP4993274B2 (ja) * 2006-12-05 2012-08-08 日医工株式会社 フェノフィブラート含有製剤組成物の製造方法
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
EP2224805A4 (en) * 2007-12-17 2013-10-16 Alpharma Pharmaceuticals Llc PHARMACEUTICAL COMPOSITION
FR2940118B1 (fr) * 2008-12-24 2013-08-09 Ethypharm Sa Formulation pharmaceutique de fenofibrate nanonise
JPWO2010092925A1 (ja) * 2009-02-12 2012-08-16 あすか製薬株式会社 固体分散体とその医薬組成物、並びにそれらの製造方法
CN101502497B (zh) * 2009-03-06 2010-11-10 安徽省药物研究所 非诺贝特药物组合物
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
KR101202994B1 (ko) * 2010-04-12 2012-11-21 한미사이언스 주식회사 페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US20140255480A1 (en) * 2011-09-07 2014-09-11 Ethypharm Pharmaceutical formulation of nanonized fenofibrate
KR101334585B1 (ko) * 2012-05-29 2013-12-05 주식회사 브이터치 프로젝터를 통해 표시되는 정보를 이용하여 가상터치를 수행하는 원격 조작 장치 및 방법
US8722083B2 (en) 2012-06-25 2014-05-13 Mylan, Inc. Fenofibrate formulation
WO2014091318A1 (en) 2012-12-11 2014-06-19 Lupin Atlantis Holdings, S.A. Reduced dose pharmaceutical compositions of fenofibrate
US20160289393A1 (en) * 2013-12-04 2016-10-06 Dow Global Technologies Llc Process for prepring a mixture of a cellulose derivative and a liquid diluent
CN104352466A (zh) * 2014-11-17 2015-02-18 辰欣药业股份有限公司 一种非诺贝特组合物及其制剂
CN107961224B (zh) * 2017-12-06 2021-05-04 齐鲁制药(海南)有限公司 一种阿昔替尼片及其制备方法
KR102407512B1 (ko) 2019-10-30 2022-06-13 주식회사 대웅테라퓨틱스 피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물
CN112121022A (zh) * 2020-09-25 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物及其制备方法
WO2022071768A1 (en) * 2020-09-29 2022-04-07 Addpharma Inc. A pharmaceutical composition comprising fenofibrate particles with improved bioavailability
CN112121023A (zh) * 2020-09-30 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058552A (en) 1969-01-31 1977-11-15 Orchimed Sa Esters of p-carbonylphenoxy-isobutyric acids
CH543472A (fr) 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
GB1579818A (en) 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4344934A (en) 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
EP0012523B2 (en) 1978-11-20 1988-02-03 American Home Products Corporation Therapeutic compositions with enhanced bioavailability and process for their preparation
FR2494112B1 (pt) * 1980-11-19 1986-01-10 Laruelle Claude
GB8414220D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
GB8414221D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Unit dosage form
FR2602423B1 (fr) 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4752470A (en) 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
US4895725A (en) * 1987-08-24 1990-01-23 Clinical Technologies Associates, Inc. Microencapsulation of fish oil
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
ES2056470T3 (es) 1990-07-02 1994-10-01 Boehringer Mannheim Gmbh Proceso para la obtencion de dosis unitarias de liberacion retardada, prensadas en molde, y las dosis unitarias correspondientes.
JP3125221B2 (ja) * 1990-09-01 2001-01-15 大正製薬株式会社 ソファルコン含有固形製剤
JP3037393B2 (ja) * 1990-10-22 2000-04-24 大正薬品工業株式会社 経口投与用固形薬剤の製造方法
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
ATE156707T1 (de) * 1991-06-21 1997-08-15 Ilsan Ilac Ve Hammaddeleri San Neues galenisches verfahren für omeprazol enthaltende pellets
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr) 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
DE19608750A1 (de) 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
EP0914100A1 (en) * 1996-06-28 1999-05-12 Schering Corporation Oral composition comprising a triazole antifungal compound
FR2758461A1 (fr) 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
AU2005299A (en) * 1997-12-20 1999-07-12 Genencor International, Inc. Fluidized bed matrix granule
JP2000086509A (ja) * 1998-09-14 2000-03-28 Taisho Yakuhin Kogyo Kk ソファルコン含有製剤の製造方法
FR2783421B1 (fr) * 1998-09-17 2000-11-24 Cll Pharma Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
US6368620B2 (en) * 1999-06-11 2002-04-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US6667064B2 (en) 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
WO2002024169A1 (en) * 2000-09-20 2002-03-28 Skyepharma Canada Inc. Spray drying process and compositions of fenofibrate
US8026281B2 (en) 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate

Also Published As

Publication number Publication date
ATE399006T1 (de) 2008-07-15
ES2271924T3 (es) 2007-04-16
BG65504B1 (bg) 2008-10-31
NO333301B1 (no) 2013-04-29
BG106280A (en) 2002-08-30
DE60039313D1 (de) 2008-08-07
EE04995B1 (et) 2008-04-15
IS6218A (is) 2002-01-03
AU782282B2 (en) 2005-07-14
UA72925C2 (uk) 2005-05-16
DK1523983T3 (da) 2008-10-13
US20070071812A1 (en) 2007-03-29
TR200200008T2 (tr) 2002-06-21
IS2157B (is) 2006-11-15
CN1682707B (zh) 2010-05-05
DE60019120T2 (de) 2006-02-09
ATE291912T1 (de) 2005-04-15
KR20020025188A (ko) 2002-04-03
EP1523983B1 (fr) 2008-06-25
FR2795961A1 (fr) 2001-01-12
HUP0202338A2 (en) 2002-10-28
WO2001003693A1 (fr) 2001-01-18
CZ20022A3 (cs) 2002-05-15
FR2795961B1 (fr) 2004-05-28
MXPA02000324A (es) 2002-06-21
IL147499A0 (en) 2002-08-14
DE60031184D1 (de) 2006-11-16
HK1044894B (zh) 2005-06-24
NO20020014L (no) 2002-03-04
SI1194140T1 (en) 2005-06-30
ES2309438T3 (es) 2008-12-16
EP1574214A1 (fr) 2005-09-14
NO20020014D0 (no) 2002-01-02
PT1523983E (pt) 2008-09-19
DE60019120D1 (de) 2005-05-04
YU93201A (sh) 2004-09-03
ME01361B (me) 2008-11-28
ATE341320T1 (de) 2006-10-15
HK1074588A1 (en) 2005-11-18
US20110159082A1 (en) 2011-06-30
EP1194140A1 (fr) 2002-04-10
US8563042B2 (en) 2013-10-22
EA200200147A1 (ru) 2002-06-27
EE200200011A (et) 2003-02-17
PL212082B1 (pl) 2012-08-31
DE60031184T2 (de) 2007-08-23
JP2011148813A (ja) 2011-08-04
CA2377909A1 (fr) 2001-01-18
HRP20020111A2 (en) 2003-04-30
ES2235919T3 (es) 2005-07-16
KR20070026716A (ko) 2007-03-08
HK1080391A1 (en) 2006-04-28
CN1204885C (zh) 2005-06-08
EP1574214B1 (fr) 2006-10-04
NZ516416A (en) 2003-10-31
CZ300094B6 (cs) 2009-01-28
KR20060073549A (ko) 2006-06-28
KR100766644B1 (ko) 2007-10-15
EP1523983A1 (fr) 2005-04-20
GEP20043287B (en) 2004-07-26
US20080248101A1 (en) 2008-10-09
CA2377909C (fr) 2011-06-28
HRP20020111B1 (en) 2005-12-31
PL352307A1 (en) 2003-08-11
DK1574214T3 (da) 2007-01-22
US7101574B1 (en) 2006-09-05
RS50035B (sr) 2008-11-28
SK152002A3 (en) 2002-07-02
DK1194140T3 (da) 2005-07-04
CY1106206T1 (el) 2011-06-08
CN1360499A (zh) 2002-07-24
SI1574214T1 (sl) 2006-12-31
HUP0202338A3 (en) 2003-03-28
EA004294B1 (ru) 2004-02-26
JP2003504331A (ja) 2003-02-04
US8658212B2 (en) 2014-02-25
ZA200200169B (en) 2002-07-31
HU229044B1 (hu) 2013-07-29
BR0012335A (pt) 2002-03-19
IL147499A (en) 2007-03-08
HK1044894A1 (en) 2002-11-08
SK287484B6 (sk) 2010-11-08
AU6296000A (en) 2001-01-30
PT1574214E (pt) 2007-01-31
CN1682707A (zh) 2005-10-19
JP4841092B2 (ja) 2011-12-21
EP1194140B1 (fr) 2005-03-30

Similar Documents

Publication Publication Date Title
PT1194140E (pt) Composicao farmaceutica contendo fenofibrato e processo de preparacao
BR0012250A (pt) Processo de fabricação de grânulos revestidos com gosto mascarado, e liberação imediata do princìpio ativo, grânulo revestido, comprimido multiparticulado de dissolução rápida e comprimido de hidrodispersibilidade rápida
IT1313618B1 (it) Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici eprocedimento per la loro preparazione.
HUP0103567A2 (hu) ORL-1 receptor agonistaként alkalmazható 2-helyzetben helyettesített 1-piperidil-benzimidazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyászati készítmények
ES2060784T3 (es) Granulos que tienen un nucleo y su produccion.
HUP0102465A3 (en) Process for the production of an aqueous monoester peroxycarboxylic acid solution, the solution obtainable by this process, and its use as disinfectant
BR0009410A (pt) Piridina-2,3-dicarboxamida, composto, uso de uma piridina-2,3-dicarboxamida, composição herbicida, composição para a dessecação e/ou desfolhação de vegetais, e, processo para controlar vegetação não desejável
WO2001095856A3 (en) Urea derivative useful as an anti-cancer agent and process for preparing same
KR970706278A (ko) 치환된 스피로알킬아미노- 및 스피로알콕시-헤테로환, 이들의 제조방법, 및 살충제 및 살진균제로서의 이들의 용도(substituted spiroalkylamino and spiroalkoxy-heterocycles, process for preparing the same and their use as pesticides and fungicides)
HUP9802995A3 (en) Substituted sulphonylamino (thio)carbonyl derivatives, intermediates, thereof herbicide compositions containing these compounds as active ingredients, process for the preparation and use of the compounds and compositions
HUP9900344A3 (en) Process for the preparation of an optically active indoline-2-carboxylic acid or derivative thereof
TR199901044T2 (en) Endos�lfan-mikrokaps�l da��l�m�.
BR9913601A (pt) Composto, uso do mesmo, composição farmacêutica, e, processo para a preparação de compostos
DK1413575T3 (da) Fremgangsmåde til fremstilling af derivater af (1,5-diaryl)pyrazol-3-ylpropansyre
FR2824069B1 (fr) Composition contenant au moins un sulfo-acetate de cellulose et au moins un tensio-actif, son procede de preparation et ses utilisations
CA2355720A1 (en) New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
EP1129712A4 (en) PREPARATIONS OF QUINOLINONE DERIVATIVES AND THEIR PRODUCTION METHOD
HUT76859A (en) 4-halo-2-fluoro-5-alkoxybenzoyl derivatives, process for preparing such compounds and intermediates thereof
EP0374125A3 (de) Bodenverbesserungsmittel
ITRM930546A0 (it) Nuovi derivati imidazolici, procedimento per la loro preparazione e loro applicazione come pesticidi.
HU9801086D0 (en) New benzofurane derivatives, pharmaceutical compositions containing them as active component and process for producing the active component
FI982846A (fi) Menetelmä ligniinin vesiseoksen stabiloimiseksi, ligniinin vesiseos ja kyseisen seoksen käyttö
RU96123357A (ru) Противопаразитарная паста для лошадей